ONO-1603, a potential antidementia drag, shows neuroprotective effects and increases m3-muscarinic receptor mRNA levels in differentiating rat cerebellar granule neurons

Neuroscience Letters

Volumn 214, Issue 2-3, 1996, Pages 151-154

  Katsube, Nobuo ^a   Sunaga, Katsuyoshi ^b   Chuang, De Maw ^c   Ishitani, Ryoichi ^b  

^a ONO PHARMACEUTICAL CO   (Japan)

^b JOSAI UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Alzheimer's disease; Antidementia; Cerebellar granule cell; Muscarinic receptor; Neurotrophic; ONO 1603; Prolyl endopeptidase inhibitor

Indexed keywords

1 [N (4 CHLOROBENZYL)SUCCINAMOYL]PROLINAL; CARBACHOL; ENZYME INHIBITOR; MESSENGER RNA; MUSCARINIC M3 RECEPTOR; PROLYL ENDOPEPTIDASE; PROLYL ENDOPEPTIDASE INHIBITOR; SCOPOLAMINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CEREBELLUM; CONTROLLED STUDY; DEMENTIA; GRANULAR CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030598930     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12912-8     Document Type: Article

References (19)

1. [1] Berridge, M.J., Downes, C.P. and Hanley, M.R., Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands, Biochem. J., 206 (1982) 587-595.
2. [2] Buxbaum, J.D., Oishi, M., Chen, H.I., Pinkas-Kramarski, R., Jaffe, E.A., Gandy, S.E. and Greengard, P., Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor, Proc. Natl. Acad. Sci. USA, 89 (1992) 10075-10078.
3. [3] Checler, F., Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease, J. Neurochem., 65 (1995) 1431-1444.
4. + channels and suppression of neuronal activity by secreted β-amyloid-precursor protein, Nature, 379 (1996) 74-78.
5. [5] Gallo, V., Kingsbury, A., Balázs, R. and Jørgensen, O.S., The role of depolarization in the survival and differentiation of cerebellar granule cells in culture, J. Neurosci., 7 (1987) 2203-2213.
6. [6] Katsube, N., Maegawa, H., Kagamiishi, Y., Yamamoto, M. and Aishita, H., ONO-1603 inhibits brain prolyl oligopeptidase in vitro, in vivo and in situ, Soc. Neurosci. Abstr., 20 (1994) 1148.
7. [7] Lee, R.K.K., Wurtman, R.J., Cox, A.J. and Nitsch, R.M., Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors, Proc. Natl. Acad. Sci. USA, 92 (1995) 8083-8087.
8. [8] Loo, D.T., Copani, A., Pike, C.J., Whittemore, E.R., Walencewicz, A.J. and Cotman, C.W., Apoptosis is induced by β-amyloid in cultured central nervous system neurons, Proc. Natl. Acad. Sci. USA, 90 (1993) 7951-7955.
9. [9] Mattson, M.P., Cheng, B., Culwell, A.R., Esch, F.S., Lieberburg, I. and Rydel, R.E., Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein, Neuron, 10 (1993) 243-254.
10. [10] Milward, E.A., Papadopoulos, R., Fuller, S.J., Moir, R.D., Small, D., Beyreuther, K. and Masters, C.L., The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth, Neuron, 9 (1992) 129-137.
11. [11] Mucke, L., Masliah, E., Johnson, W.B., Ruppe, M.D., Alford, M., Rockenstein, E.M., Forss-Petter, S., Pietropaolo, M., Mallory, M. and Abraham, C.R., Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice, Brain Res., 666 (1994) 151-167.
12. [12] Nitsch, R.M., Slack, B.E., Wurtman, R.J. and Growdon, J.H., Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors, Science, 258 (1992) 304-307.
13. [13] Summers, W.K., Majovski, L.V., Marsch, G.M., Tachiki, K. and Kling, A., Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type, N. Engl. J. Med., 315 (1986) 1241-1245.
14. [14] Sunaga, K., Chuang, D.-M. and Ishitani, R., Tetrahydroaminoacridine is neurotrophic and promotes the expression of muscarinic receptor-coupled phosphoinositide turnover in differentiating cerebellar granule cells, J. Pharmacol. Exp. Ther., 264 (1993) 463-468.
15. 2-, muscarinic acetylcholine receptor mRNA levels in differentiating cerebellar granule cells, Neurosci. Lett., 163 (1993) 27-30.
16. [16] Walter, R., Shlank, H., Glass, J.D., Schwartz, I.L. and Kerenyi, T.D., Leucylglycinamide released from oxytocin by human enzyme, Science, 173 (1971) 827-829.
17. [17] Wilk, S., Prolyl endopeptidase, Life Sci., 33 (1983) 2149-2157.
18. [18] Wurtman, R.J., The return of the cholinergic hypothesis, J. Clin. Invest., 94 (1994) 470.
19. [19] Zager, E.L. and Black, P.M., Neuropeptides in human memory and learning processes, Neurosurgery, 17 (1985) 355-369.